On January 15th 2003, the European Patent Office has granted final patent protection (EP 1275377A1) to APR's proprietary technology for the preparation of granulates containing liposoluble substances. More
Morphochem AG and Xenogen Corp. today announced that both companies have entered into a research collaboration to discover targets and develop compounds effective against bacterial biofilms. More
Morphochem and GBF have entered into a research collaboration in the area of cancer research, the objective of which is to develop new therapeutics using tubulysins. More
STOCKHOLM, SWEDEN—Her Majesty the Queen of Sweden will officially open the Salk Institute's annual International Council meeting at the Grand Hotel in Stockholm. More